🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of camlipixant i...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-04-08
Trial ID
NCT07519395
Treatments Being Tested
This study is a single center, single dose, open-label, randomly assigned 2...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-07-09
Trial ID
NCT06497517
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-11-21
Trial ID
NCT07650084
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2022-12-05
Trial ID
NCT05600777
This is a phase 1, 2-part, open-label, fixed-sequence study evaluating pote...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-26
Trial ID
NCT05959447
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-25
Trial ID
NCT05599191
This is an open-label study being conducted in healthy adults, to learn wha...
Status
Suspended
Location
GSK Investigational Site
Start Date
2026-07-02
Trial ID
NCT07684586
Treatments Being Tested
The purpose of this study is to assess the effect of Hepatic impairment (HI...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-02-02
Trial ID
NCT06222892
Treatments Being Tested
This is a phase 1, 2-part, open-label, fixed-sequence study evaluating the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-06-21
Trial ID
NCT05899829
Treatments Being Tested